Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda

Simple item page
dc.contributor.authorWalusimbi, Simon
dc.contributor.authorKwesiga, Brendan
dc.contributor.authorRodrigues, Rashmi
dc.contributor.authorHaile, Melles
dc.contributor.authorde Costa, Ayesha
dc.contributor.authorBogg, Lennart
dc.contributor.authorKatamba, Achilles
dc.date.accessioned2023-01-17T19:58:59Z
dc.date.available2023-01-17T19:58:59Z
dc.date.issued2016
dc.description.abstractMicroscopic Observation Drug Susceptibility (MODS) and Xpert MTB/Rif (Xpert) are highly sensitive tests for diagnosis of pulmonary tuberculosis (PTB). This study evaluated the cost effectiveness of utilizing MODS versus Xpert for diagnosis of active pulmonary TB in HIV infected patients in Uganda. Methods: A decision analysis model comparing MODS versus Xpert for TB diagnosis was used. Costs were estimated by measuring and valuing relevant resources required to perform the MODS and Xpert tests. Diagnostic accuracy data of the tests were obtained from systematic reviews involving HIV infected patients. We calculated base values for unit costs and varied several assumptions to obtain the range estimates. Cost effectiveness was expressed as costs per TB patient diagnosed for each of the two diagnostic strategies. Base case analysis was performed using the base estimates for unit cost and diagnostic accuracy of the tests. Sensitivity analysis was performed using a range of value estimates for resources, prevalence, number of tests and diagnostic accuracy. Results: The unit cost of MODS was US$ 6.53 versus US$ 12.41 of Xpert. Consumables accounted for 59 % (US$ 3.84 of 6.53) of the unit cost for MODS and 84 % (US$10.37 of 12.41) of the unit cost for Xpert. The cost effectiveness ratio of the algorithm using MODS was US$ 34 per TB patient diagnosed compared to US$ 71 of the algorithm using Xpert. The algorithm using MODS was more cost-effective compared to the algorithm using Xpert for a wide range of different values of accuracy, cost and TB prevalence. The cost (threshold value), where the algorithm using Xpert was optimal over the algorithm using MODS was US$ 5.92. Conclusions: MODS versus Xpert was more cost-effective for the diagnosis of PTB among HIV patients in our setting. Efforts to scale-up MODS therefore need to be explored. However, since other non-economic factors may still favour the use of Xpert, the current cost of the Xpert cartridge still needs to be reduced further by more than half, in order to make it economically competitive with MODS.en_US
dc.identifier.citationWalusimbi, S., Kwesiga, B., Rodrigues, R., Haile, M., de Costa, A., Bogg, L., & Katamba, A. (2016). Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda. BMC Health Services Research, 16(1), 1-10. DOI 10.1186/s12913-016-1804-9en_US
dc.identifier.uri10.1186/s12913-016-1804-9
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/7001
dc.language.isoenen_US
dc.publisherBMC Health Services Researchen_US
dc.subjectCost-effectivenessen_US
dc.subjectMODSXpert MTB/Rifen_US
dc.subjectDiagnosisen_US
dc.subjectTuberculosisen_US
dc.subjectHIVen_US
dc.titleCost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Ugandaen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Cost-effectiveness analysis of microscopic.pdf
Size:
803.87 KB
Format:
Adobe Portable Document Format
Description:
Article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences